Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
NCT ID: NCT00150449
Last Updated: 2006-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
511 participants
INTERVENTIONAL
2001-01-31
2006-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pregabalin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed any protocol specified withdrawal phase and follow-up visits.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Bangor, Northern Ireland, United Kingdom
Pfizer Investigational Site
Greenisland, Carrickfergus, Northern Ireland, United Kingdom
Pfizer Investigational Site
Houston, Renfrewshire, United Kingdom
Pfizer Investigational Site
A-1040 Wien, , Austria
Pfizer Investigational Site
Vienna, , Austria
Pfizer Investigational Site
Wein, , Austria
Pfizer Investigational Site
Brussels, , Belgium
Pfizer Investigational Site
De Pinte, , Belgium
Pfizer Investigational Site
Ghent, , Belgium
Pfizer Investigational Site
Kortrijk, , Belgium
Pfizer Investigational Site
Lede, , Belgium
Pfizer Investigational Site
Liège, , Belgium
Pfizer Investigational Site
Sint-Denijs-Westrem, , Belgium
Pfizer Investigational Site
Tielt, , Belgium
Pfizer Investigational Site
Tournai, , Belgium
Pfizer Investigational Site
Tallinn, , Estonia
Pfizer Investigational Site
Tartu, , Estonia
Pfizer Investigational Site
Reims, Cedex, France
Pfizer Investigational Site
Denguin, , France
Pfizer Investigational Site
Élancourt, , France
Pfizer Investigational Site
Metz, , France
Pfizer Investigational Site
Montesson, , France
Pfizer Investigational Site
Montigny-lès-Metz, , France
Pfizer Investigational Site
Saint-Étienne-du-Grès, , France
Pfizer Investigational Site
Wasquehal, , France
Pfizer Investigational Site
Bad-Deurrheim, , Germany
Pfizer Investigational Site
Bremerhaven, , Germany
Pfizer Investigational Site
Göttingen, , Germany
Pfizer Investigational Site
Göttingen, , Germany
Pfizer Investigational Site
Hamburg, , Germany
Pfizer Investigational Site
Köthen, , Germany
Pfizer Investigational Site
Lauf, , Germany
Pfizer Investigational Site
Oldenburg, , Germany
Pfizer Investigational Site
Osnabrück, , Germany
Pfizer Investigational Site
Siegen, , Germany
Pfizer Investigational Site
Spaichingen, , Germany
Pfizer Investigational Site
Ness Ziona, , Israel
Pfizer Investigational Site
Bassano Del Grappa (Vicenza), , Italy
Pfizer Investigational Site
Bologna, , Italy
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Roma, , Italy
Pfizer Investigational Site
Riga, , Latvia
Pfizer Investigational Site
BV Losser, , Netherlands
Pfizer Investigational Site
GC Nijmegen, , Netherlands
Pfizer Investigational Site
Hoogvliet, , Netherlands
Pfizer Investigational Site
Huizen, , Netherlands
Pfizer Investigational Site
Losser, , Netherlands
Pfizer Investigational Site
RC Dordrecht, , Netherlands
Pfizer Investigational Site
Vlaardinger-Ambacht, , Netherlands
Pfizer Investigational Site
Zwigndrecht, , Netherlands
Pfizer Investigational Site
Zwijndreacht, , Netherlands
Pfizer Investigational Site
Zwijndrecht, , Netherlands
Pfizer Investigational Site
Zwijndrecht, , Netherlands
Pfizer Investigational Site
Zwijndrecht, , Netherlands
Pfizer Investigational Site
Bialystok, , Poland
Pfizer Investigational Site
Bydgoszcz, , Poland
Pfizer Investigational Site
Katowice, , Poland
Pfizer Investigational Site
Olsztyn, , Poland
Pfizer Investigational Site
Torun, , Poland
Pfizer Investigational Site
Tuszyn, , Poland
Pfizer Investigational Site
Warsaw, , Poland
Pfizer Investigational Site
Wroclaw, , Poland
Pfizer Investigational Site
Zabrze, , Poland
Pfizer Investigational Site
Goodwood, Cape Town, South Africa
Pfizer Investigational Site
Paarl, Cape Town, South Africa
Pfizer Investigational Site
Kempton Park, Johannesburg, South Africa
Pfizer Investigational Site
Rosebank, Johannesburg, South Africa
Pfizer Investigational Site
Hatfield, Pretoria, South Africa
Pfizer Investigational Site
Bellville, , South Africa
Pfizer Investigational Site
Bloemfontein, , South Africa
Pfizer Investigational Site
Bloemfontein, , South Africa
Pfizer Investigational Site
East London, , South Africa
Pfizer Investigational Site
George, , South Africa
Pfizer Investigational Site
Hurlingham, Johannesburg, , South Africa
Pfizer Investigational Site
Pinetown Natal, , South Africa
Pfizer Investigational Site
Polokwane, , South Africa
Pfizer Investigational Site
Pretoria, , South Africa
Pfizer Investigational Site
Pretoria, , South Africa
Pfizer Investigational Site
Sandton, , South Africa
Pfizer Investigational Site
Somerset West, , South Africa
Pfizer Investigational Site
Westville, , South Africa
Pfizer Investigational Site
Granollers, Barcelona, Spain
Pfizer Investigational Site
Oviedo, Principality of Asturias, Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Pamplona, , Spain
Pfizer Investigational Site
Seville, , Spain
Pfizer Investigational Site
Zaragoza, , Spain
Pfizer Investigational Site
Kharkiv, , Ukraine
Pfizer Investigational Site
Lviv, , Ukraine
Pfizer Investigational Site
Odesa, , Ukraine
Pfizer Investigational Site
Maidenhead, Berkshire, United Kingdom
Pfizer Investigational Site
Slough, Berks, United Kingdom
Pfizer Investigational Site
Falmouth, Cornwall, United Kingdom
Pfizer Investigational Site
Fowey, Cornwall, United Kingdom
Pfizer Investigational Site
Penzance, CORNWALL, United Kingdom
Pfizer Investigational Site
Saltash, Cornwall, United Kingdom
Pfizer Investigational Site
St Austell, CORNWALL, United Kingdom
Pfizer Investigational Site
Downpatrick, County Down, United Kingdom
Pfizer Investigational Site
Chesterfield, Derbyshire, United Kingdom
Pfizer Investigational Site
Plymouth, Devon, United Kingdom
Pfizer Investigational Site
Bexhill-on-Sea, EAST SUSSEX, United Kingdom
Pfizer Investigational Site
Bexhill-on-Sea, East Sussex, United Kingdom
Pfizer Investigational Site
Leigh-on-Sea, Essex, United Kingdom
Pfizer Investigational Site
Leslie, Fife, United Kingdom
Pfizer Investigational Site
Limekilns, Fife, United Kingdom
Pfizer Investigational Site
Cathcart, Glasgow, United Kingdom
Pfizer Investigational Site
Clarckston, Glasgow, United Kingdom
Pfizer Investigational Site
Rutherglen, Glasgow, United Kingdom
Pfizer Investigational Site
Bolton, Lancashire, United Kingdom
Pfizer Investigational Site
Chelsea, London, United Kingdom
Pfizer Investigational Site
Epworth, Doncaster, South Yorkshire, United Kingdom
Pfizer Investigational Site
Saint John's, Woking, Surrey, United Kingdom
Pfizer Investigational Site
Trowbridge, WILTSHIRE, United Kingdom
Pfizer Investigational Site
Inkberrow, Worcestershire, United Kingdom
Pfizer Investigational Site
Birmingham, , United Kingdom
Pfizer Investigational Site
Bolton, , United Kingdom
Pfizer Investigational Site
Bolton, , United Kingdom
Pfizer Investigational Site
Chesterfield, , United Kingdom
Pfizer Investigational Site
Cookstown, , United Kingdom
Pfizer Investigational Site
Coventry, , United Kingdom
Pfizer Investigational Site
Coventry, , United Kingdom
Pfizer Investigational Site
Coventry, , United Kingdom
Pfizer Investigational Site
Coventry, , United Kingdom
Pfizer Investigational Site
Dundee, , United Kingdom
Pfizer Investigational Site
Earlsdon, Coventry, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Leeds, , United Kingdom
Pfizer Investigational Site
London, , United Kingdom
Pfizer Investigational Site
Port Glasgow, , United Kingdom
Pfizer Investigational Site
Rugby, , United Kingdom
Pfizer Investigational Site
, ,
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Montgomery S, Emir B, Haswell H, Prieto R. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Curr Med Res Opin. 2013 Oct;29(10):1223-30. doi: 10.1185/03007995.2013.820694. Epub 2013 Aug 19.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1008-100
Identifier Type: -
Identifier Source: org_study_id